Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics
Back Lund, PK (2005) 'The discovery of glucagon-like peptide 1', Regulatory Peptides , 93-96
Improved Metabolic Health Improves insulin sensitivity and stabilizes blood sugar
Best peptide approach : BPC-157 primary Protocol : BPC-157: 250-500mcg twice daily 6-8 weeks Can inject near ankle Expected results : 50-70% improvement, better stability, reduced swelling
Most patients notice reduced appetite and early weight loss within the first 2-4 weeks
In stock Ipamorelin Swipe right to view full table Peptide Partners Manufacturer Id : WF03 Batch Id : IP202601 Authors : K Raun, B S Hansen, N L Johansen, H Thgersen, K Madsen, M Ankersen, P H Andersen Source : In vitro, ipamorelin released GH from primary rat pituitary cells with a potency and efficacy similar to GHRP-6 (EC50 = 1.3+/-0.4nmol/l and Emax = 85+/-5% vs 2.2+/-0.3nmol/l and 100%)